Allosterically Targeting EGFR Drug-Resistance Gatekeeper Mutations

Journal of Thoracic Disease - Hong Kong
doi 10.21037/jtd.2017.06.43
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AME Publishing Company

Related search

EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors

Clinical Cancer Research
Cancer ResearchOncology
2015English

Targeting Oncoprotein Stability Overcomes Drug Resistance Caused by FLT3 Kinase Domain Mutations

PLoS ONE
Multidisciplinary
2014English

Akt Kinase-Interacting Protein1, a Novel Therapeutic Target for Lung Cancer With EGFR-activating and Gatekeeper Mutations

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Targeting Autophagy for Overcoming Resistance to Anti-Egfr Treatments

Cancers
Cancer ResearchOncology
2019English

Overcoming Drug Resistance by Co-Targeting

2010English

Targeting Efflux Pumps to Overcome Antifungal Drug Resistance

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2016English

EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.13-15 Detection of EGFR Mutations in cfDNA and Development of Resistance

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients

Oncology Reports
MedicineCancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy